NASDAQ:BMRN
BioMarin Pharmaceutical Inc.
- Stock
locale
United Statesmarket
STOCKSindustry
Biotechnologywebsite
www.biomarin.comipo date
Jul 26, 1999
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-acetylgalactosamine 4-sulfatase fo...Show More
Earnings
Earnings Release TomorrowEarnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus